Study authors: Ida Rask Moustsen-Helms, Hanne-Dorthe Emborg, Jens Nielsen, Katrine Finderup Nielsen, Tyra Grove Krause, Kåre Mølbak, Karina Lauenborg Møller, Ann-Sofie Nicole Berthelsen, Palle Valentiner-Branth The study: This is a pre-print (not yet peer reviewed) of the first study to report vaccine effectiveness specifically for a long-term care facility population. The population-based cohort study assessed vaccine effectiveness (VE) of the BNT162b2 mRNA vaccine (developed by Pfizer/ BioNTech) in all Long-term Care Facilities (LTCF) … Continue reading Article summary: Vaccine effectiveness after 1st and 2nd dose of the BNT162b2 mRNA (Pfizer/BioNTech) Covid-19 vaccine in long-term care facility residents and healthcare workers – a Danish cohort study (pre-print)